EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma

Wei Li iD, Guangnan Huang iD, Lizhong Zeng, Wenhui Dang iD, Ting Jiao, Yonghong Zhang, Mengying Zhang, Shuru Zhou, Liping Chen, Shuanying Yang iD

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 29.10.2026. Verfasst von Wei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an City, Shaanxi Province, China. Hauptthemen laut MEDLINE: Mast Cells, Lung Neoplasms, Adenocarcinoma of Lung, Biomarkers, Tumor. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Natural Science Basic Research Program of Shaanxi, the Key Research and Development Program of Shaanxi, Science and technology program of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Component C1q binding protein (C1QBP) is known as an important regulator of mitochondrial plasticity and is involved in antitumor immune response in cancers. Nevertheless, its role in lung adenocarcinoma (LUAD) still remains largely unknown.

Methods

C1QBP expression in LUAD and adjacent normal samples was compared by Wilcoxon test, and the corresponding receiver operating characteristic (ROC) curve was used to estimate its diagnostic value. Associations between C1QBP expression levels and different clinical traits were analyzed by chi‐square test; K‐M curves were applied for analyzing survival differences, and univariate and multivariate Cox analysis were employed to construct the C1QBP ‐related nomogram model. Furthermore, GSEA and immune analysis were performed to explore the mechanism. Finally, rhC1QBP was applied to cultured mast cells in vivo to investigate its regulatory effect on mast cell dysfunction, and sh‐C1QBP was injected into LUAD xenograft mice to explore the effect of C1QBP knockdown on tumor growth in vivo.

Results

The C1QBP expression level, with a preferable diagnosis effect, was significantly different between LUAD and normal samples, and was notably interrelated with gender, TNM stage, and Fustat in LUAD patients. LUAD patients with high C1QBP levels displayed lower survival rates. Our nomogram based on C1QBP expression and T stage displayed decent prediction capability. There was a significant difference in C1QBP expression in plasma cells, regulatory T cells (Tregs), activated CD4 memory T cells, resting mast cells, and eosinophils between LUAD patients and the controls. Upregulation of C1QBP with rhC1QBP treatment promoted mast cell ferroptosis through interacting with the Cullin3 protein. While Fer‐1, a ferroptosis inhibitor, counteracted rhC1QBP induced ferroptosis in mast cells. Knockdown of C1QBP inhibited tumor growth in xenograft mice.

Conclusion

C1QBP may be a promising potential prognostic biomarker in LUAD and a potential therapeutic target by affecting the immune microenvironment of LUAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsLung NeoplasmsAdenocarcinoma of LungBiomarkers, TumorCarrier ProteinsMitochondrial ProteinsReceptors, ComplementHumansAnimalsFemalePrognosisMaleMiceMiddle AgedCell Line, Tumor

Stichwörter der Autor:innen

C1QBPdiagnosis and prognosisimmune microenvironmentlung adenocarcinomamast cell ferroptosis

Substanzen

C1QBP protein, humanBiomarkers, TumorCarrier ProteinsMitochondrial ProteinsReceptors, Complement

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an City, Shaanxi Province, China.
  • Department of Respiratory and Critical Care Medicine, Bainiaohu Branch of People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi City, Xinjiang Uigur Autonomous Region, China.

ORCID-Profile: Wei Li, Guangnan Huang, Wenhui Dang, Shuanying Yang

Förderung

  • the Natural Science Basic Research Program of Shaanxi
  • the Key Research and Development Program of Shaanxi
  • Science and technology program of Xinjiang Uygur Autonomous Region

Zitieren

APA

Li, W., Huang, G., Zeng, L., Dang, W., Jiao, T., Zhang, Y., Zhang, M., Zhou, S., Chen, L., & Yang, S. (2026). High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72394

Vancouver

Li W, Huang G, Zeng L, Dang W, Jiao T, Zhang Y, et al. High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72394

BibTeX
@article{Li2026,
  author = {Li, Wei and Huang, Guangnan and Zeng, Lizhong and Dang, Wenhui and Jiao, Ting and Zhang, Yonghong and Zhang, Mengying and Zhou, Shuru and Chen, Liping and Yang, Shuanying},
  title = {High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72394}
}
Kostenlos starten →